PET显像在临床无反应患者中的诊断价值
本文综述意识障碍的临床分类及FDG-PET在临床无反应患者中的诊断与预后价值,指出FDG-PET可一致显示各种意识障碍中脑葡萄糖摄取代谢减低,可能有助于鉴别最小意识状态与无反应觉醒综合征,但预测临床结局的效力尚需更大样本更长随访研究。
要点
- FDG-PET可一致显示各种意识障碍中脑葡萄糖摄取代谢减低。
- FDG-PET可能有助于鉴别最小意识状态与无反应觉醒综合征。
- 床旁临床评估误诊意识障碍仍是重要问题。
核心结论
- FDG-PET可能是一致的工具,用于显示各种意识障碍中脑葡萄糖摄取代谢减低,并可能有助于鉴别最小意识状态与无反应觉醒综合征。
- FDG-PET可用于评估意识障碍患者功能紊乱的程度和范围以及识别不可逆神经损伤。
- 这些发现预测临床结局的效力尚需更大样本、更长随访的意识障碍患者研究。
研究设计与样本
- 本文为综述文章,讨论意识障碍的临床分类及PET显像在临床无反应患者中的诊断与预后价值。
诊断标准与关键数值
- 当前临床指南基于临床研究设置推荐PET用于诊断和/或预后目的。
临床应用与阅片要点
- 当前临床指南基于临床研究设置推荐PET用于诊断和/或预后目的。
- 床旁临床评估中意识障碍的误诊仍是重要问题。
局限性
- 这些发现预测临床结局的效力尚需更大样本、更长随访的意识障碍患者研究。
- 本文考虑了PET显像在此类情况下已知的局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Rapid advancements in the critical care management of acute brain injuries have facilitated the survival of numerous patients who may have otherwise succumbed to their injuries. The probability of conscious recovery hinges on the extent of structural brain damage and the level of metabolic and functional cerebral impairment, which remain challenging to assess via laboratory, clinical, or functional tests. Current research settings and guidelines highlight the potential value of fluorodeoxyglucose-PET (FDG-PET) for diagnostic and prognostic purposes, emphasizing its capacity to consistently illustrate a metabolic reduction in cerebral glucose uptake across various disorders of consciousness. Crucially, FDG-PET might be a pivotal tool for differentiating between patients in the minimally conscious state and those in the unresponsive wakefulness syndrome, a persistent clinical challenge. In patients with disorders of consciousness, PET offers utility in evaluating the degree and spread of functional disruption, as well as identifying irreversible neural damage. Further, studies that capture responses to external stimuli can shed light on residual or revived brain functioning. Nevertheless, the validity of these findings in predicting clinical outcomes calls for additional long-term studies with larger patient cohorts suffering from consciousness impairment. Misdiagnosis of conscious illnesses during bedside clinical assessments remains a significant concern. Based on the clinical research settings, current clinical guidelines recommend PET for diagnostic and/or prognostic purposes. This review article discusses the clinical categories of conscious disorders and the diagnostic and prognostic value of PET imaging in clinically unresponsive patients, considering the known limitations of PET imaging in such contexts.
引用
- Farg H, Elnakib A, Gebreil A, et al. Diagnostic value of PET imaging in clinically unresponsive patients. Br J Radiol. 2024. PMID: 38308033. doi:10.1093/bjr/tqad040
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。